Star Lake Bioscience Co., Inc.Zhaoqing Guangdong (SHA:600866)
China
· Delayed Price · Currency is CNY 7.35
-0.01 (-0.14%)
May 23, 2025, 2:45 PM CST
SHA:600866 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 16,550 | 16,710 | 16,891 | 17,074 | 3,970 | 1,106 | Upgrade
|
| Other Revenue | 624.13 | 624.13 | 482.72 | 412.8 | 100.95 | 10.21 | Upgrade
|
| Revenue | 17,174 | 17,334 | 17,374 | 17,486 | 4,071 | 1,116 | Upgrade
|
| Revenue Growth (YoY) | -1.35% | -0.23% | -0.64% | 329.51% | 264.72% | 6.35% | Upgrade
|
| Cost of Revenue | 13,966 | 14,393 | 14,976 | 14,488 | 3,276 | 750.43 | Upgrade
|
| Gross Profit | 3,208 | 2,942 | 2,397 | 2,998 | 794.87 | 365.84 | Upgrade
|
| Selling, General & Admin | 1,064 | 1,076 | 947.17 | 935.84 | 365.04 | 139.39 | Upgrade
|
| Research & Development | 167.36 | 169.78 | 179.31 | 177.98 | 98.83 | 57.64 | Upgrade
|
| Other Operating Expenses | 110.14 | 104.97 | 80.35 | 118.9 | 8.21 | 13.14 | Upgrade
|
| Operating Expenses | 1,340 | 1,346 | 1,213 | 1,236 | 469.21 | 210.5 | Upgrade
|
| Operating Income | 1,869 | 1,596 | 1,185 | 1,762 | 325.66 | 155.35 | Upgrade
|
| Interest Expense | -100.41 | -109.68 | -173.46 | -243.29 | -83.35 | -13.88 | Upgrade
|
| Interest & Investment Income | 15.35 | 14.85 | 21.43 | 15.5 | 7.26 | 7.75 | Upgrade
|
| Currency Exchange Gain (Loss) | 37.4 | 37.4 | -8.33 | -76.91 | 6.6 | -2.36 | Upgrade
|
| Other Non Operating Income (Expenses) | -27.77 | -19.65 | -14.12 | -40.35 | 4.97 | -0.23 | Upgrade
|
| EBT Excluding Unusual Items | 1,793 | 1,519 | 1,010 | 1,417 | 261.14 | 146.63 | Upgrade
|
| Impairment of Goodwill | -91.91 | -91.91 | -93.7 | -12.34 | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | -218.7 | -237.67 | -66.94 | 3.6 | 8.79 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 28.63 | 28.69 | 0.3 | 4.35 | 0.83 | 1.12 | Upgrade
|
| Asset Writedown | -19.4 | -6.9 | -14.15 | -17.14 | -4.31 | -6.87 | Upgrade
|
| Other Unusual Items | 21.55 | 21.92 | 27.88 | 27.72 | 11.81 | 15.77 | Upgrade
|
| Pretax Income | 1,513 | 1,233 | 863.62 | 1,424 | 278.26 | 156.64 | Upgrade
|
| Income Tax Expense | 340.52 | 283.27 | 177.92 | 240.56 | 29.18 | 7.93 | Upgrade
|
| Earnings From Continuing Operations | 1,173 | 949.81 | 685.7 | 1,183 | 249.07 | 148.71 | Upgrade
|
| Minority Interest in Earnings | -7.1 | -6.66 | -7.74 | -574.66 | -96.94 | - | Upgrade
|
| Net Income | 1,166 | 943.15 | 677.95 | 608.33 | 152.14 | 148.71 | Upgrade
|
| Net Income to Common | 1,166 | 943.15 | 677.95 | 608.33 | 152.14 | 148.71 | Upgrade
|
| Net Income Growth | 44.12% | 39.12% | 11.45% | 299.85% | 2.31% | -0.56% | Upgrade
|
| Shares Outstanding (Basic) | 1,661 | 1,661 | 1,662 | 1,188 | 807 | 739 | Upgrade
|
| Shares Outstanding (Diluted) | 1,661 | 1,661 | 1,662 | 1,188 | 807 | 739 | Upgrade
|
| Shares Change (YoY) | 0.01% | -0.02% | 39.91% | 47.23% | 9.14% | 0.03% | Upgrade
|
| EPS (Basic) | 0.70 | 0.57 | 0.41 | 0.51 | 0.19 | 0.20 | Upgrade
|
| EPS (Diluted) | 0.70 | 0.57 | 0.41 | 0.51 | 0.19 | 0.20 | Upgrade
|
| EPS Growth | 44.11% | 39.14% | -20.34% | 171.58% | -6.26% | -0.59% | Upgrade
|
| Free Cash Flow | 2,091 | 1,759 | 1,650 | 1,210 | -181.59 | -39.91 | Upgrade
|
| Free Cash Flow Per Share | 1.26 | 1.06 | 0.99 | 1.02 | -0.23 | -0.05 | Upgrade
|
| Dividend Per Share | 0.380 | 0.380 | 0.380 | - | - | - | Upgrade
|
| Gross Margin | 18.68% | 16.97% | 13.80% | 17.15% | 19.52% | 32.77% | Upgrade
|
| Operating Margin | 10.88% | 9.21% | 6.82% | 10.08% | 8.00% | 13.92% | Upgrade
|
| Profit Margin | 6.79% | 5.44% | 3.90% | 3.48% | 3.74% | 13.32% | Upgrade
|
| Free Cash Flow Margin | 12.18% | 10.15% | 9.50% | 6.92% | -4.46% | -3.57% | Upgrade
|
| EBITDA | 2,697 | 2,429 | 2,035 | 2,742 | 429.11 | 243.28 | Upgrade
|
| EBITDA Margin | 15.71% | 14.01% | 11.71% | 15.68% | 10.54% | 21.79% | Upgrade
|
| D&A For EBITDA | 828.46 | 832.89 | 850.63 | 979.49 | 103.45 | 87.93 | Upgrade
|
| EBIT | 1,869 | 1,596 | 1,185 | 1,762 | 325.66 | 155.35 | Upgrade
|
| EBIT Margin | 10.88% | 9.21% | 6.82% | 10.08% | 8.00% | 13.92% | Upgrade
|
| Effective Tax Rate | 22.50% | 22.97% | 20.60% | 16.90% | 10.49% | 5.06% | Upgrade
|
| Revenue as Reported | 17,174 | 17,334 | 17,374 | 17,486 | 4,071 | 1,116 | Upgrade
|
| Advertising Expenses | - | 51.05 | 62.42 | 17.7 | 4.96 | 1.87 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.